News | November 06, 2025
Marksans Pharma’s UK Arm Relonchem secures MHRA nod for Exemestane 25mg Tablets
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Everolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients in kidney and liver transplantation
Ticagrelor tablets are indicated for reducing the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Triamcinolone Acetonide injectable suspension USP is indicated for various autoimmune, inflammatory, and other conditions
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Rifaximin tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy
Subscribe To Our Newsletter & Stay Updated
